OPX Raises $3.6M in Venture Funding and Appoints Robert Chess Chairman and CEO

BOULDER, Colo. -- OPX Biotechnologies, Inc., a new company dedicated to enabling economically viable biofuels and biorefined chemicals, announced that it has secured $3.6 million in venture funding led by MDV -- Mohr Davidow Ventures (Menlo Park, Calif.). OPX also appointed Robert B. Chess as Chairman and CEO and established its board of directors. Link.